Stifel Nicolaus Increases Trupanion (NASDAQ:TRUP) Price Target to $40.00

Trupanion (NASDAQ:TRUP) had its price target increased by research analysts at Stifel Nicolaus from $30.00 to $40.00 in a report issued on Monday, Benzinga reports. The firm presently has a “hold” rating on the financial services provider’s stock. Stifel Nicolaus’ target price indicates a potential downside of 6.54% from the company’s previous close.

A number of other research firms also recently weighed in on TRUP. William Blair initiated coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating for the company. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Northland Securities boosted their price target on shares of Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday. Bank of America lifted their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday. Finally, Piper Sandler increased their target price on Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a report on Friday, August 9th. Four analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $40.67.

Trupanion Stock Performance

Trupanion stock opened at $42.80 on Monday. Trupanion has a fifty-two week low of $19.14 and a fifty-two week high of $49.14. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The stock has a market cap of $1.80 billion, a P/E ratio of -66.88 and a beta of 1.74. The firm’s fifty day moving average price is $40.56 and its 200-day moving average price is $31.75.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The business had revenue of $314.80 million for the quarter, compared to the consensus estimate of $309.33 million. During the same quarter last year, the business posted ($0.33) earnings per share. The company’s revenue for the quarter was up 16.3% on a year-over-year basis. On average, equities research analysts expect that Trupanion will post -0.37 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders have sold 8,764 shares of company stock valued at $405,238 over the last ninety days. 5.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Trupanion

Several hedge funds and other institutional investors have recently modified their holdings of TRUP. ProShare Advisors LLC lifted its holdings in Trupanion by 33.8% in the first quarter. ProShare Advisors LLC now owns 121,417 shares of the financial services provider’s stock worth $3,352,000 after buying an additional 30,645 shares during the period. Susquehanna Fundamental Investments LLC purchased a new position in shares of Trupanion in the 1st quarter valued at approximately $473,000. 8 Knots Management LLC bought a new stake in shares of Trupanion during the fourth quarter valued at approximately $21,165,000. Seven Eight Capital LP purchased a new stake in Trupanion in the fourth quarter worth $1,399,000. Finally, Quest Partners LLC purchased a new stake in Trupanion in the fourth quarter worth $67,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.